Salofalk

In the US, Salofalk (mesalamine systemic) is a member of the drug class 5-aminosalicylates and is used to treat Crohn's Disease - Maintenance, Ulcerative Colitis - Active and Ulcerative Colitis - Maintenance.

US matches:

• Salofalk Rectal

UK matches:

• Salofalk 1.5g gastro-resistant prolonged release granules
• Salofalk 1000mg Granules
• Salofalk 500mg gastro-resistant prolonged release granules
• Salofalk Enema 2g
• Salofalk Rectal Foam 1g
• Salofalk Suppositories 500mg
• Salofalk 1.5g gastro-resistant prolonged release granules (SPC)
• Salofalk 1000mg gastro-resistant prolonged release granules (SPC)
• Salofalk 1g Suppositories (SPC)
• Salofalk 250mg Tablets (SPC)
• Salofalk 500mg gastro-resistant prolonged release granules (SPC)
• Salofalk 500mg gastro-resistant tablets (SPC)
• Salofalk Enema 2g (Dr. Falk Pharma UK Ltd) (SPC)
• Salofalk Rectal Foam 1g (SPC)
• Salofalk Suppositories 500mg (Dr. Falk Pharma UK Ltd) (SPC)

Ingredient matches for Salofalk

Mesalazine

Mesalazine is reported as an ingredient of Salofalk in the following countries:

• Argentina


• Australia


• Austria


• Bosnia & Herzegowina


• Bulgaria


• Canada


• Chile


• China


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Estonia


• Finland


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Latvia


• Lithuania


• Malaysia


• Malta


• Mexico


• Netherlands


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Serbia


• Singapore


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• Thailand


• Turkey


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.